This research focuses on the development of a PCSK9 vaccine and its implications for cardiology, alongside the integration of digital innovation.
Assessing the current state of PCSK9 vaccine research.
Evaluating the use of artificial intelligence in cardiology practices.
Examining organizational efforts to transition to digital working.
Identified significant advancements in PCSK9 vaccine research.
Highlighted challenges in the transition to AI applications in cardiology.
Noted the potential for improved patient outcomes through digital transformation.
Abstract
The Miriam Hospital and its parent organization, Lifespan, with a continued interest in the transition to digital working and use of artificial intelligence in cardiology.